257 related articles for article (PubMed ID: 24794101)
1. Comparative efficacy and risk of harms of immediate- versus extended-release second-generation antidepressants: a systematic review with network meta-analysis.
Nussbaumer B; Morgan LC; Reichenpfader U; Greenblatt A; Hansen RA; Van Noord M; Lux L; Gaynes BN; Gartlehner G
CNS Drugs; 2014 Aug; 28(8):699-712. PubMed ID: 24794101
[TBL] [Abstract][Full Text] [Related]
2. Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis.
Reichenpfader U; Gartlehner G; Morgan LC; Greenblatt A; Nussbaumer B; Hansen RA; Van Noord M; Lux L; Gaynes BN
Drug Saf; 2014 Jan; 37(1):19-31. PubMed ID: 24338044
[TBL] [Abstract][Full Text] [Related]
3. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis.
Gartlehner G; Hansen RA; Morgan LC; Thaler K; Lux L; Van Noord M; Mager U; Thieda P; Gaynes BN; Wilkins T; Strobelberger M; Lloyd S; Reichenpfader U; Lohr KN
Ann Intern Med; 2011 Dec; 155(11):772-85. PubMed ID: 22147715
[TBL] [Abstract][Full Text] [Related]
4. Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.
Gartlehner G; Gaynes BN; Hansen RA; Thieda P; DeVeaugh-Geiss A; Krebs EE; Moore CG; Morgan L; Lohr KN
Ann Intern Med; 2008 Nov; 149(10):734-50. PubMed ID: 19017592
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis.
Wagner G; Schultes MT; Titscher V; Teufer B; Klerings I; Gartlehner G
J Affect Disord; 2018 Mar; 228():1-12. PubMed ID: 29197738
[TBL] [Abstract][Full Text] [Related]
6. Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials.
Maneeton N; Maneeton B; Srisurapanont M; Martin SD
BMC Psychiatry; 2012 Sep; 12():160. PubMed ID: 23017200
[TBL] [Abstract][Full Text] [Related]
7. Second-generation antidepressants for preventing seasonal affective disorder in adults.
Gartlehner G; Nussbaumer B; Gaynes BN; Forneris CA; Morgan LC; Kaminski-Hartenthaler A; Greenblatt A; Wipplinger J; Lux LJ; Sonis JH; Hofmann J; Van Noord MG; Winkler D
Cochrane Database Syst Rev; 2015 Nov; (11):CD011268. PubMed ID: 26558418
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.
Hansen RA; Gartlehner G; Lohr KN; Gaynes BN; Carey TS
Ann Intern Med; 2005 Sep; 143(6):415-26. PubMed ID: 16172440
[TBL] [Abstract][Full Text] [Related]
9. Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis.
Gartlehner G; Thieda P; Hansen RA; Gaynes BN; Deveaugh-Geiss A; Krebs EE; Lohr KN
Drug Saf; 2008; 31(10):851-65. PubMed ID: 18759509
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine.
Maneeton N; Maneeton B; Eurviriyanukul K; Srisurapanont M
Drug Des Devel Ther; 2013; 7():1053-62. PubMed ID: 24101861
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
[TBL] [Abstract][Full Text] [Related]
12. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
13. Nonpharmacologic and Pharmacologic Treatments of Adult Patients With Major Depressive Disorder: A Systematic Review and Network Meta-analysis for a Clinical Guideline by the American College of Physicians.
Gartlehner G; Dobrescu A; Chapman A; Toromanova A; Emprechtinger R; Persad E; Affengruber L; Pieh C; Klerings I; Wagner G
Ann Intern Med; 2023 Feb; 176(2):196-211. PubMed ID: 36689750
[TBL] [Abstract][Full Text] [Related]
14. The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis.
Gartlehner G; Thaler K; Hansen RA; Gaynes BN
Drug Saf; 2009; 32(12):1159-73. PubMed ID: 19916583
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review.
Thaler KJ; Morgan LC; Van Noord M; Gaynes BN; Hansen RA; Lux LJ; Krebs EE; Lohr KN; Gartlehner G
Depress Anxiety; 2012 Jun; 29(6):495-505. PubMed ID: 22553134
[TBL] [Abstract][Full Text] [Related]
16. Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis.
Amick HR; Gartlehner G; Gaynes BN; Forneris C; Asher GN; Morgan LC; Coker-Schwimmer E; Boland E; Lux LJ; Gaylord S; Bann C; Pierl CB; Lohr KN
BMJ; 2015 Dec; 351():h6019. PubMed ID: 26645251
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
[TBL] [Abstract][Full Text] [Related]
18. Second-generation antidepressants for seasonal affective disorder.
Thaler K; Delivuk M; Chapman A; Gaynes BN; Kaminski A; Gartlehner G
Cochrane Database Syst Rev; 2011 Dec; (12):CD008591. PubMed ID: 22161433
[TBL] [Abstract][Full Text] [Related]
19. Systematic review and meta-analysis of second-generation antidepressants for the treatment of older adults with depression: questionable benefit and considerations for frailty.
Mallery L; MacLeod T; Allen M; McLean-Veysey P; Rodney-Cail N; Bezanson E; Steeves B; LeBlanc C; Moorhouse P
BMC Geriatr; 2019 Nov; 19(1):306. PubMed ID: 31718566
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]